Vyant Bio Inc. buy tamam
Start price
07.12.17
/
50%
€303.08
Target price
07.12.18
€811.80
Performance (%)
-90.00%
End price
07.12.18
€30.30
Summary
This prediction ended on 07.12.18 with a price of €30.30. The BUY prediction by tamam for Vyant Bio Inc. performed very badly with a performance of -90.00%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vyant Bio Inc. | - | - | - | - |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% | 65.619% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% | 111.545% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% | 56.683% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% | 68.722% |
Comments by tamam for this prediction
In the thread Cancer Genetics Inc. diskutieren
tamam stimmt der Buy-Einschätzung von melinda zu
tamam stimmt am 07.12.2017 der Buy-Einschätzung von melinda aber mit dem Kursziel 6 $ zu.
Überschrift: diagnostics
Cancer Genetics (NASDAQ:CGIX) initiated with Buy rating and $6 (179% upside) price target by Maxim Group.
(Laufzeit überschritten)